TOPIC 15:ANTITRUST AND INTELLECTUAL PROPERTY RIGHTS Topic 15| Part 29 January 2014 Date ANTITRUST ECONOMICS 2013 David S. Evans University of Chicago,

Slides:



Advertisements
Similar presentations
Licensing Issues Research In Motion Limited ETSI IPRR#01 meeting January 2006.
Advertisements

Negotiating Technology License Agreements Tamara Nanayakkara.
Standard Essential Patents in Infringement Litigations - Orange-Book-Approach and latest developments Conference on Information Technology, Innovation.
Patent settlements in the EU EGA perspective Ingrid Vandenborre 18 October 2013.
CHAPTER 8 PRICING Study Objectives
 These materials are public information and have been prepared for entertainment purposes only to contribute to the fascinating study of intellectual.
Trade-Offs by Harold Winter
IP rights and competition law: Friends or foes? Etienne Wéry Attorney at the bars of Paris and Brussels Lecturer at Robert Schuman University (Strasbourg)
Principles of FRAND Royalties Norman Siebrasse University of Toronto Patent Colloquium 2014.
Seeking, and enforcing, an injunction by a patent-holder as an antitrust abuse ? The emerging picture in the EU Alison Jones University of Toronto Patent.
National symposium on Competition law: Evolution and Transition, 2012 Competition Policy for IP Issues Pradeep S Mehta Secretary General, CUTS International.
Page 1 15th ITS World Conference September 2004 Dr. Jan Krancke T-Mobile International Who is afraid of Market Dynamics ? The Regulatory Leviathan.
© 2008 Prentice Hall Business Publishing Economics R. Glenn Hubbard, Anthony Patrick O’Brien, 2e. Fernando & Yvonn Quijano Prepared by: Chapter 14 Monopoly.
Economics: Principles in Action
1 Is there a conflict between competition law and intellectual property rights? Edward Whitehorn Head, Competition Affairs Branch Carrie Tang Assistant.
Changes in Demand and Market Processes. Profits and Avocadoes Firms will grow avocadoes only if they can make a profit To make a profit, price must cover.
Skadden, Arps, Slate, Meagher & Flom LLP Andrew Thomases: Consequences of RAND Violations | 1 Consequences of RAND Violations Andrew Thomases.
What is Commercialization of IP Josiah Hernandez.
Authorized Generics: Good For Everyone (Even Generics) Jerome A. Swindell Senior Counsel.
TILEC – T ILBURG L AW AND E CONOMICS C ENTER Innovation: a challenge for law Pierre Larouche Professor of Competition Law Colloquium.
H I R S C H & P A R T N E R S A v o c a t S o l i c i t o r R e c h t s a n w a l t Pharmaceutical settlement agreements and competition law A litigation.
Introductory course on Competition and Regulation Pál Belényesi University of Verona October 2006.
The FTC, Pharmaceuticals, Antitrust & IP: A Grab Bag October 23, 2008 This presentation was prepared from public sources. The views expressed herein do.
The ECJ's Huawei/ZTE judgment (C-170/13) Thomas Kramler DG Competition, European Commission (The views expressed are not necessarily those of the European.
Antitrust. “Is there not a causal connection between the development of these huge, indomitable trusts and the horrible crimes now under investigation?
1 FRAND COMMITMENTS AND EU COMPETITION LAW Thomas Kramler European Commission, DG Competition (The views expressed are not necessarily those of the European.
How to assess vertical mergers cast your vote! Miguel de la Mano* Member of the Chief Economist Team DG COMP, European Commission *The views expressed.
Merger Remedies By Kenneth L. Danger Presented at the OECD-Korea Regional Centre for Competition.
PowerPoint Slides prepared by: Andreea CHIRITESCU Eastern Illinois University Monopoly 1 © 2012 Cengage Learning. All Rights Reserved. May not be copied,
Unit 4, Lesson 10 Competition AOF Business Economics Copyright © 2008–2011 National Academy Foundation. All rights reserved.
Competition Policy and Law Presentation to Study Tour for Russian Member Universities of the Virtual Institute Network 26 March 2009.
Essential Facility and Refusal to deal. Property Rights & Antitrust Antonio Nicita.
26/28/04/2014 – IP for Innovation HG Dynamic Use of Industrial Property for Innovation Growth, Competitiveness and Market Access Heinz Goddar Boehmert.
Slide title 70 pt CAPITALS Slide subtitle minimum 30 pt Standard essential patents And frand licensing – the need for a balanced approach Ulrika Wester,
1 WIPO-KIPO-KIPA IP Panorama Business School, October 6 to 10, 2008 IP Strategies in Standards Setting Tomoko Miyamoto Senior Counsellor, Patent Law Section.
Law in the Global Marketplace: Intellectual Property and Related Issues Hosted by: FRAND in Europe: Huawei vs ZTE decision.
Exclusionary Conduct in the Context of Standard Setting William E. Cohen Deputy General Counsel for Policy Studies U.S. Federal Trade Commission Views.
1 AIPPI Forum 2011 Hyderabad, India, 15 October AIPPI Forum 2011 Hyderabad, India, 15 October 2011 Standardisation and Software Protection Strategies.
ABA China Inside and Out September , Beijing The interface between competition law and intellectual property Nicholas Banasevic, DG Competition,
IP Related Competition Issues Prof. Dr. Peter Chrocziel Freshfields Bruckhaus Deringer Frankfurt am Main DF
© Hogan & Hartson LLP. All rights reserved. Monopoly Power: Getting it and keeping it US Perspective Sharis Pozen, Partner ACCE Seminar 13 May 2008.
Chapter 22: The Competitive Firm Copyright © 2013 by The McGraw-Hill Companies, Inc. All rights reserved. McGraw-Hill/Irwin 13e.
Session 30: FRAND Licensing Disputes NJA Advanced Course on Commercial Matters Bhopal, India January 23, 2016 Richard Tan, Chartered Arbitrator, Singapore.
Recent Japanese Cases Regarding Standard Essential Patents and FRAND Licensing Declaration AIPLA-IPHC Meeting April 11, 2013 Shinji ODA Judge, Intellectual.
Patent Pools – Issues of Dominance and Royalty Setting Marleen Van Kerckhove ABA Brown Bag Presentation March 20 th, 2007.
Exercise of IP rights as an abusive behaviour under EU antitrust law Christian Vollrath European Commission DG Competition 1.
Chapter 5 The Free Enterprise System. Traits of Private Enterprise Section 5.1.
Standards and competition policy EU-China Workshop on Application of Anti-monopoly Law in Intellectual Property Area Changsha, 11. – 12. March 2010 Peter.
Identification of Abuse of dominant market position involving IPR Wang Xianlin, KoGoan Law School of Shanghai Jiaotong University Dalian,June 11,2010.
Sangmin Song, Director, Anti-Monopoly Div., KFTC MRFTA & IP Rights 1.
Market Structures Chapter 7. PERFECT COMPETITION Section One.
Recent FTC Pharmaceutical Cases: Background and Examples Sue H. Kim This presentation was prepared from public sources. The views expressed herein do not.
European Commission, DG Competition, Policy and Strategy, International Relations 1 New EU Competition Rules for Purchase and Distribution agreements Kris.
Latonia Gordon Microsoft NJTIP 10 th Anniversary Symposium Chicago, March 7-8, 2013 The views expressed herein are solely those of the author; they should.
Stephen S. Korniczky Anti-Suit Injunctions – Leveling the Playing Field When Seeking a FRAND License to Standard-Essential.
Dialogue on Competition Policy and Intellectual Property *
Legal Considerations ETSI Seminar © ETSI All rights reserved.
Competition Law and Cellphone Patents
EU Competition Rules for Technology Transfer Agreements
International Conference on Judicial Protection of IPR
Time Warner Rules Manhattan
African Competition Forum
The new technology transfer regime More evolution than revolution
International Conference on Judicial Protection of IPR
Voluntary Codes and Standards
Arbitration – Telecoms Industry
Itumeleng Lesofe Competition Commission South Africa
Standards and competition law Michael Adam DG Competition, European Commission (speaking in a personal capacity - the views expressed are not necessarily.
The role of injunctions in FRAND proceedings – a UK perspective
Update on IP and Antitrust
Presentation transcript:

TOPIC 15:ANTITRUST AND INTELLECTUAL PROPERTY RIGHTS Topic 15| Part 29 January 2014 Date ANTITRUST ECONOMICS 2013 David S. Evans University of Chicago, Global Economics Group Elisa Mariscal CIDE, Global Economics Group

2 Overview Part 1 Overview of IP Rights Economics of Intellectual Property Tension Between Antitrust and IP Protection Licensing of IP Part 2 Economics of Contracting Refusal to Supply IP Rights FRAND, SEPS, and SSOs Pay for Delay

3 Current Issues in Antitrust and Intellectual Property Refusal to Supply IP Rights IP rights holder refuses to make IP available at any price Microsoft “Interoperability” decision in EU FRAND Commitments to SSOs Holder of standard essential patents (SEPs) requires “high” royalty Google Motorola Mobility commitments with FTC on not seeking injunctions to enforce SEPs Pay for Delay Settlements Branded and generic pharma settle patent litigation by branded paying generic to delay entry US Supreme Court decision in Actavis All of these cases involve a bilateral contract negotiation. Antitrust issues result from problems with that negotiation. Failure to reach deal in the case of refusal to supply and injunctions for SEPs. Nature of deal for pharma patent settlements.

Bargaining and Contracts 4

5 Bilateral Negotiation with Buyers and Seller Common for businesses to enter into contract negotiations with each other. Considerable portion of B2B exchanges are based on contracts, some simple, some very complex.

6 Deals Happen Between Threat Points Most the buyer is willing to pay Least the seller is willing to take Deal can take place between these “threat points”

7 Bargaining Power Availability of substitutes. Buyer power. Lack of sunk costs and precommitments. Repeat purchases. For buyer: Alternative customers for excludable goods. Credible threat to withhold product. Any lock-ins of customer. For seller:

8 Other Determinants of Bargaining Outcome Whether the buyer knows other sales prices or the seller’s true minimum Whether the seller knows the buyer’s willingness to pay and the demand faced by buyer Information asymmetries Some buyers or sellers are better at negotiating deals Negotiating ability Buyers and sellers have more of an incentive to reach “fair” outcome if there are repeated interactions Also, know more about threat points in repeated games Repeated games

9 Deals Don’t Necessarily Happen Most the buyer is willing to pay Least the seller is willing to take Seller won’t take as little as the buyer is willing to offer. No deal possible! This situation is important for some of the antitrust debates because the claim is seller is “refusing to supply” in effect or charging an “unfair price”.

10 Contracts are Multifaceted PriceQualityServiceLength Some business contracts are very complicated, deal with many dimensions involving exchange of value, and address contingencies including breach of contract.

11 Contracts, Bargaining, and the Antitrust of IP Refusal to supply: refusal for leverage, or buyer isn’t willing to pay the seller’s minimum price? FRAND: Licensor isn’t offering FRAND or buyer would like a better deal? Reverse payments: contract to settle litigation in the face of uncertainty or contract to create and share monopoly profits?

Refusal to Supply Intellectual Property 12

13 Classic Refusal to Supply Cases European Commission decision on Microsoft (Interoperability) (2004) and European General Court judgment (2008). Referral of IMS Health Case to European Court (2004) European Commission decision on Magill’s access to television listings of RTE, ITP, and BBC (1988) and European Court of Justice judgment (1995) Note, following Trinko, refusal to supply essentially per se lawful in US.

14 Key Economic Issues Does owner of IP have incentive and ability to leverage IP to secure additional monopoly profit? Raises standard vertical issues including whether Chicago single monopoly profit theorem holds and whether benefit of additional profit outweighs cost of lost revenue. Does refusal result in the exclusion of competition necessary to make refusal profitable? Are there efficiency benefits, including dynamic ones, from refusal such as prevention of free-riding and eliminating double marginalization? How should incentives to innovate be accounted for? Questions: (1) Could a dominant firm refuse on grounds that the price buyer is willing to pay isn’t enough to offset its loss of revenues in downstream market in which it also competes? (2) How do we account for the incentives that “monopoly profits” play in inducing innovation in the first place?

15 Economics of Refusal to Supply Pre-Microsoft Not objectively justified Prevents the emergence of a new product Refusal excludes all competition in secondary market Property indispensable to compete Refusal per se lawful, but for “exceptional circumstances” Microsoft European General Court judgment adopted easier test for Commission to meet. Must show “risk of elimination of competition” and impedes technological development which is short of prevention of new product. Court considers balancing incentives to innovate from providing access versus reduced incentives from forced sharing.

16 Economics of “New Products”: Q P MC Value of New Product (increases from zero to this value (minus perhaps value of products it has displaced) Demand Reflects policy judgment not to interfere with property rights and incentives of firms to invest and innovate except in extreme cases including—in particular—creation of new product. Limits interventions to ones where dynamic benefits of compulsory licensing outweigh dynamic costs of compulsory licensing.

FRANDS, SSOs, and SEPs 17

18 A Guide to the Alphabet Soup of Patents SSO : Standard Setting Organization is usually a non-profit association of companies and other entities that devise technical standards. SEP : Standard Essential Patent is a patent that claims an invention that must be used to comply with a technical standard generally enunciated by an SSO. There could be hundreds, maybe thousands, of these for a standard. FRAND : SSOs often require that members agree to disclose patents on technologies to be included in a standard and agree to license those patents on “fair, reasonable, and non-discriminatory terms”. Some SSOs do not include the word “fair” in which case there are RAND obligations. Note that FRAND agreement requires that members license patent and therefore forbid an outright refusal to supply.

19 Standard Setting Organizations in Action “ETSI's purpose is to produce and perform the maintenance of the technical standards and other deliverables which are required by its members (Article 2 of the ETSI Statutes - see ETSI Directives). Like most standards organizations, much of this work is carried out in committees and working groups composed of technical experts from the Institute's member companies and organizations. These committees are often referred to as 'Technical Bodies' (TB), and typically meet between two and six times a year, in the ETSI premises or elsewhere. They also rely heavily on electronic communications to help progress the work, especially in- between meetings.”ETSI Directives'Technical Bodies' (TB) “When an ESSENTIAL IPR relating to a particular STANDARD or TECHNICAL SPECIFICATION is brought to the attention of ETSI, the Director-General of ETSI shall immediately request the owner to give within three months an irrevocable undertaking in writing that it is prepared to grant irrevocable licences on fair, reasonable and non-discriminatory (“FRAND”) terms and conditions under such IPR…” “With some 33,000 granted patents, Ericsson is the largest holder of standard-essential patents for mobile communication. Our unrivalled patent portfolio covers 2G, 3G and 4G technologies, and we are a net receiver of licensing royalties with more than 100 patent-licensing agreements in place.”

20 FRAND Disputes Potential licensee approaches FRAND holder to secure license which it needs to rely on for standard technology. What if the two parties can’t reach an agreement on the FRAND royalty rate? The potential licensee may choose to go without a license and let the patent holder sue. In a patent dispute the court may find the patent isn’t valid or set a royalty less than what the patent holder wanted. The patent holder may seek an injunction which if provided would prevent the licensee from using the technology unless it can find a work around.

21 Patent Hold Up Patent “hold up ”: having gotten its patent incorporated into the technology the patent holder (remember this might be one of hundreds of patents) can prevent firms from participating in the technology and therefore various markets by refusing to license except on very high terms. Could do this for “exploitative” reasons or for “exclusionary” reasons. Reverse patent hold up : patent holder can’t prevent potential licensee from using the patent except by hiring lawyers and pursuing a court challenge which can be expensive and with uncertain outcomes. And then the potential licensee could also try to pursue antitrust action which raises further risks. Question: Technologies involve hundreds of SEPs and industries can involve multiple standards. Yet there are only a small number of patent disputes relative to the total possible and, while one could argue that innovation could be faster, many SEP-heavy industries seem to be growing quickly. But maybe the handful of disputes are very serious.

22 Incremental Value Proposition Does the SEP holder get to charge more because the patent has been included in a standard? No, that would give every SEP holder the ability to gain up to full return from the standard by blocking anyone from using it. “Incremental value” of a given SEP is the difference in royalty rate that SEP could command over the next best alternative technology for a standard. That is how much SSO would have agreed to in a hypothetical negotiation. Broad consensus among economists and courts on incremental value being the right approach conceptually.

23 FRAND Disputes—Breach of Contract Approach SEP holder often has a contract with SEO that requires commitment to license at FRAND. Patent dispute with licensee is essentially a contract dispute where the parties can’t reach agreement on terms required under the contract. Microsoft v. Motorola Mobility (Judge Robart) analyzed FRAND as a hypothetical negotiation. Follows US “Georgia Pacific Factors” which is used in patent infringement cases to determine reasonable royalty rate. Consistent with economic bargaining model.

24 Sometimes Parties Just Don’t Agree

25 FRAND Determination Under Contract Theory Most the buyer is willing to pay Least the seller is willing to take Finder of fact tries to determine royalty rate that willing buyer and seller would negotiate Key factors include (1) comparable patent negotiations (same patent, other parties); different but similar patents; (2) (incremental) value of patent; (3) bargaining power.

26 Antitrust Theories Concerning FRAND and SEPs “Unfair/Excessive” Pricing (“Exploitative Abuse”): for jurisdictions that have unfair pricing as part of antitrust law. Theory is that SEP confers dominant position and patent holder is trying to charge excessive price (see Huawei v. InterDigital, China) Refusal to supply : patent holder is asking for such a high price that it is in effect a refusal to supply. Standard essential facility argument. Exclusionary abuse (1) : patent holder is charging high price to exclude potential licensee from a downstream market (margin squeeze argument). Exclusionary abuse (2) : by filing for injunction patent holder is engaging in unfair competition that results in high prices.

27 Tests Under Antitrust or Contract Theories Assessment under antitrust theories require assessment of “FRAND” price to determine whether the patent holder is exceeding FRAND. Shapiro et al. recommend using “incremental value”. But requires finder of fact to assess incremental value relative to other alternatives. Schmalensee et al. recommend using “hypothetical negotiation” since this fills into contract and is operational under traditional patent approaches. Robarts decision in Microsoft v. Motorola rejects incremental value approach in favor of hypothetical negotiation largely for reasons of it being a practical approach.

Pay for Delay 28

29 Reverse Payment Settle aka Pay-for-Delay Company A (patent holder) sues Company B (potential infringer) for patent infringement. “Typical settlement”: B agrees to pay A and/or B agrees to pay royalty. “Reverse payment settlement”: A agrees to pay B and B agrees to “pay for delay” of competitive entry. Cases so far have involved A being branded pharmaceutical suing generic pharmaceutical B. But in principle could be other industries. US Hatch-Waxman law allows generic to challenge branded pharmaceutical and in return get 6 months of generic monopoly if successful. First generic that sues gets first entry slot. In US pay for delay therefore results in not only B being delayed but all generics being delayed since B is first in line.

30 Settlement Economics Factors (Simple Model) P= probability of winning patent litigation for A T=remaining patent lifetime in yearsM=monopoly profits in years for AD=duopoly profits in years for AC=A’s cost of litigating patentR=reverse paymentE=Entry date for B Reverse payment settlement involves choosing R and E EM+(T-E)D>(PM+(1-P)D)T-C Patentee settles with R payment and E entry date if certain monopoly profits during delayed entry minus reverse payments exceed expected value of monopoly profits minus litigation costs.

31 Settlement Terms and Consumer Welfare Simple Shapiro (2003) Model Patentee settles with R payment and E entry date if certain monopoly profits during delayed entry minus reverse payments exceed expected value of monopoly profits minus litigation costs. EM+(T-E)D>(PM+(1-P)D)T-C Consumers are worse off if they get on average more monopoly under settlement than they would under litigation which happens if the expected duration of the patent (PT) from litigation (assuming instantaneous result in litigation) is less than the delay (E) negotiated under the settlement. Shapiro rule is that the reverse payment settlement is anticompetitive if reverse payment (R) is greater than the avoided cost of litigation. Otherwise patentee is paying for delay that harms consumers. In complex settlements R is based on net value received by potential entrant for delay after deducing any value conveyed to patentee.

32 Supreme Court Actavis Decision Solvay agreed to pay generic companies between $10 million and over $100 million not to enter until a future date (but before patent expiration). FTC challenged. Lower courts affirmed that reverse patent settlements were within patent scope. FTC sought to rule finding reverse payment settlements “presumptively illegal” (parties could rebut presumption). Supreme Court decided rule of reason finding that there may be legitimate justifications for settlement but might also be method to secure and divide monopoly profits. Likely validity of patent is one issue in assessing whether reverse payment is anticompetitive or not. How should rule of reason be structured? How does risk of antitrust liability affect decision to enter into procompetitive reverse payment settlements?.

33 Next Class Topic 16 Part 1 Antitrust Economics of Telecommunications Part 2 Antitrust Economics of Payments